Celebrity aesthetician Angela Caglia is set to launch her highly anticipated Cell Forté Serum exclusively at Violet Grey, while also revealing that her brand has received funding from former Sephora CEO Martin Brok, WWD reported.
The Cell Forté Serum, priced at $395, will be released on October 2nd. It claimed that their goal was to develop stem cell technology that avoids the controversy of embryonic stem cells and the ineffectiveness of plant stem cells.
The brand projects that sales of the serum will reach $5 million over the next 12 months. Additionally, Angela Caglia is also developing other stock keeping units within the range to further expand her brand’s offerings.
Regarding the investment from Martin Brok, Caglia shared that they were introduced through a mutual acquaintance. Brok, who previously served as the CEO of Sephora and currently sits on the board of Revlon, has not only invested in Caglia’s brand but also acts as an advisor. Caglia praised Brok for his consumer-centric perspective and his support in positioning the product in the broader market.
The specifics of the investment were not disclosed, but Caglia mentioned that Brok initially invested earlier this year and has since doubled his investment. In a statement, Brok expressed his belief in Angela Caglia’s vision, stating, “I believe that Angela Caglia, with her passion for stem cell technology, has created a novel product that is at the forefront of medical science, bringing the latest scientific knowledge to the beauty industry.”
This recent investment follows Angela Caglia’s successful closure of her first funding round in March. While details of that deal were not shared, it was revealed that the round was led by a private individual, further fueling the brand’s growth and development in the competitive skincare industry.
